|
|
|
Home > In Vitro Diagnostics |
|
|
|
|
In Vitro Diagnostics Market Research Reports |
Tumor Markers: US, Europe, Japan--Strategic Profiles of Leading Cancer Diagnostic Reagent and Instrument Suppliers, Country Volume and Sales Forecasts
This report provides estimates of the number of laboratories performing tumor marker assays, as well as test volume and sales forecasts by country. The report also presents strategic analyses of leading current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
|
|
|
$3850.00 |
|
|
|
|
Tumor Markers, and Strategic Profiles of Leading Reagent and Instrument Suppliers
This report presents comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others.
|
|
|
$3850.00 |
|
|
|
|
2023 Tumor Marker Testing Technologies and Strategic Profiles of Leading Suppliers
This report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for tumor markers technologies. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy.
|
|
|
$3850.00 |
|
|
|
|
Drugs of Abuse: 2023 Analysis of the Point-of-Care Testing Market: US, Germany, Spain, Physician Offices, Emergency Rooms, Ambulatory Care Centers
This new report from Venture Planning Group provides a comprehensive analysis of the POC drugs of abuse testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC abused drugs market.
|
|
|
$3850.00 |
|
|
|
|
2023 Blood Bank Instrumentation Review: Transfusion Diagnostic Testing Analyzers and Strategic Profiles of Leading Suppliers
This report reviews current instrumentation technologies, and compares features of leading transfusion diagnostic automated and semi-automated analyzers.
|
|
|
$3850.00 |
|
|
|
|
2023 Emerging Transfusion Diagnostic Technologies and Strategic Profiles of Leading Suppliers
This report provides assessments of such technologies as molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered blood components, blood preservation, autologous blood transfusion/freezing and their potential applications for transfusion diagnostic.
|
|
|
$3850.00 |
|
|
|
|
Transfusion Diagnostics: US, Europe, Japan--Strategic Profiles of Leading Blood Bank Reagent and Instrument Suppliers, Country Volume and Sales Forecasts
This report provides a worldwide overview of the Transfusion Diagnostic Testing market, including estimates of facilities performing blood banking tests, as well as test volume, reagent and instrument sales forecasts for blood typing, grouping and infectious disease screening tests by country. The report also presents analyses of leading current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$3850.00 |
|
|
|
|
2023 Transfusion Diagnostic Typing, Grouping and NAT Screening Tests, and Strategic Profiles and Leading Reagent and Instrument Suppliers
This report presents a comprehensive analysis of the clinical significance and market needs for major transfusion diagnostic typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing innovative blood banking technologies and products.
|
|
|
$3850.00 |
|
|
|
|
Current and Emerging Microbiology Tests: Emerging Assays and Companies Developing New Technologies and Products
This report provides a comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for nearly 80 infectious diseases and viruses, including their scientific background, clinical significance and market needs for both current and emerging tests, vaccines, drugs and extensive listings of companies developing or marketing new technologies and products.
|
|
|
$3850.00 |
|
|
|
|
Microbiology: US, Europe, Japan--Strategic Profiles of Leading Instrument and Reagent Suppliers, Country Volume and Sales Forecasts
This report provides a worldwide overview of the microbiology testing market environment, structure, size and growth. The report includes estimates of the number of laboratories performing microbiology tests, as well as test volume and sales forecasts by country....
|
|
|
$3850.00 |
|
|
|
|
Microbiology Tests, and Strategic Profiles of Leading Reagent and Instrument Suppliers
This report presents a comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for nearly 100 infectious diseases and viruses, including their scientific background, clinical significance and market needs for new tests, vaccines, drugs and extensive listings of companies developing or marketing innovative technologies and products.
|
|
|
$3850.00 |
|
|
|
|
Microbiology Instrumentation: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics--Infectious Disease Testing Analyzers and Strategic Profiles of Leading Suppliers
This report reviews major analyzers used for infectious disease testing, including their operating characteristics, features and selling prices. The report also presents strategic assessments of leading market players and emerging suppliers with innovative technologies and products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$3850.00 |
|
|
|
|
Microbiology Testing Technologies and Strategic Profiles of Leading Suppliers
This report provides detailed analyses of current and emerging technologies, and their potential applications for the microbiology testing market, including molecular diagnostics, biochips, monoclonal antibodies, immunoassays, IT, gel microdroplets, differential light scattering, chromatography and several others.
|
|
|
$3850.00 |
|
|
|
|
Hemostasis Tests, and Strategic Profiles of Leading Reagent and Instrument Suppliers
This report presents the clinical significance and market needs for major hemostasis laboratory tests, as well as extensive listings of companies developing or marketing innovative coagulation technologies and products.
|
|
|
$3850.00 |
|
|
|
|
Hemostasis Laboratory and POC Testing Instrumentation, and Strategic Profiles of Leading Suppliers
This report reviews current instrumentation technologies, and compares features of leading automated and semiautomated analyzers.
|
|
|
$3850.00 |
|
|
|
|
2019 World Nucleic Acid Testing/NAT Market: US, Europe, Japan--Strategic Profiles of Leading Molecular Diagnostic Reagent and Instrument Suppliers, Country Volume and Sales Forecasts
This report provides a worldwide overview of the nucleic acid testing market, including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well as test volume and sales forecasts by country. The report also presents strategic profiles of current and emerging suppliers of nucleic acid testing products in terms of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
|
|
|
$3850.00 |
|
|
|
|
2016 Emerging Nucleic Acid Testing Assays, and Strategic Profiles of Leading Reagent and Instrument Suppliers
This 549-page report presents an overview of the clinical significance and market needs for major current and emerging NAT assays, as well as extensive listings of companies developing and marketing innovative technologies and products.
|
|
|
$3850.00 |
|
|
|
|
2015 Nucleic Acid Testing/NAT Instrumentation Review: Molecular Diagnostic Analyzers and Strategic Profiles of Leading Suppliers
This 129-page report is designed to help suppliers identify and evaluate emerging opportunities for further automating molecular diagnostics methods in order to facilitate their penetration into the routine clinical laboratory market. Some instrumentation is already available on the market, e....
|
|
|
$3850.00 |
|
|
|
|
|